Home/Saccharo/Susan Hershenson, PhD
SH

Susan Hershenson, PhD

COO

Saccharo

Therapeutic Areas

Saccharo Pipeline

DrugIndicationPhase
SAC-253Oncology (broad potential)Preclinical